<?xml version="1.0" encoding="UTF-8"?>
<experiments version="1.2" revision="100915" total="1"
	total-samples="11" total-assays="11">
	<experiment>
		<species>Homo sapiens</species>
		<rawdatafiles available="true" />
		<processeddatafiles available="true" />
		<sampleattribute>
			<category>age</category>
			<value>18 week</value>
			<value>19 week</value>
			<value>19.5 week</value>
			<value>20.5 week</value>
			<value>21 week</value>
			<value>23 week</value>
			<value>25 week</value>
			<value>25.5 week</value>
		</sampleattribute>
		<sampleattribute>
			<category>biosource type</category>
			<value>frozen_sample</value>
		</sampleattribute>
		<sampleattribute>
			<category>developmental stage</category>
			<value>fetus</value>
		</sampleattribute>
		<sampleattribute>
			<category>disease state</category>
			<value>normal</value>
			<value>thanatophoric dysplasia</value>
		</sampleattribute>
		<sampleattribute>
			<category>Organism</category>
			<value>Homo sapiens</value>
		</sampleattribute>
		<sampleattribute>
			<category>organism part</category>
			<value>cartilage</value>
		</sampleattribute>
		<sampleattribute>
			<category>sex</category>
			<value>female</value>
			<value>male</value>
			<value>unknown sex</value>
		</sampleattribute>
		<sampleattribute>
			<category>targeted cell type</category>
			<value>chondrocyte</value>
		</sampleattribute>
		<experimentalfactor>
			<name>disease state</name>
			<value>normal</value>
			<value>thanatophoric dysplasia</value>
		</experimentalfactor>
		<miamescores>
			<reportersequencescore>1</reportersequencescore>
			<protocolscore>0</protocolscore>
			<factorvaluescore>1</factorvaluescore>
			<derivedbioassaydatascore>1</derivedbioassaydatascore>
			<measuredbioassaydatascore>1</measuredbioassaydatascore>
			<overallscore>4</overallscore>
		</miamescores>
		<id>241404</id>
		<accession>E-MEXP-2276</accession>
		<name>Transcription profiling by array of chondrocytes from human
			fetuses with thanatophoric dysplasia</name>
		<experimenttype>transcription profiling by array</experimenttype>
		<releasedate>2009-12-27</releasedate>
		<lastupdatedate>2014-05-02</lastupdatedate>
		<samples>11</samples>
		<assays>11</assays>
		<arraydesign>
			<id>11119</id>
			<accession>A-AFFY-44</accession>
			<name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]
			</name>
			<count>11</count>
			<legacy_id>405156763</legacy_id>
		</arraydesign>
		<bioassaydatagroup>
			<id />
			<name>rawData</name>
			<bioassaydatacubes>11</bioassaydatacubes>
			<arraydesignprovider />
			<dataformat>rawData</dataformat>
			<bioassays>11</bioassays>
			<isderived>0</isderived>
		</bioassaydatagroup>
		<bioassaydatagroup>
			<id />
			<name>scan</name>
			<bioassaydatacubes>11</bioassaydatacubes>
			<arraydesignprovider />
			<dataformat>scan</dataformat>
			<bioassays>11</bioassays>
			<isderived>0</isderived>
		</bioassaydatagroup>
		<bioassaydatagroup>
			<id />
			<name>processedDataMatrix</name>
			<bioassaydatacubes>1</bioassaydatacubes>
			<arraydesignprovider />
			<dataformat>processedDataMatrix</dataformat>
			<bioassays>1</bioassays>
			<isderived>1</isderived>
		</bioassaydatagroup>
		<bibliography>
			<accession>19898608</accession>
			<authors>Schibler L, Gibbs L, Benoist-Lasselin C, Decraene C,
				Martinovic J, Loget P, Delezoide AL, Gonzales M, Munnich A, Jais JP,
				Legeai-Mallet L.</authors>
			<title>New insight on FGFR3-related chondrodysplasias molecular
				physiopathology revealed by human chondrocyte gene expression
				profiling</title>
			<doi>10.1371/journal.pone.0007633</doi>
			<status>published</status>
		</bibliography>
		<provider>
			<contact>Jean-Philippe JAIS</contact>
			<role>submitter</role>
			<email>jais@necker.fr</email>
		</provider>
		<experimentdesign>co-expression</experimentdesign>
		<experimentdesign>disease state</experimentdesign>
		<experimentdesign>in vitro</experimentdesign>
		<experimentdesign>reference</experimentdesign>
		<experimentdesign>replicate</experimentdesign>
		<description>
			<id />
			<text>Endochondral ossification is the process by which the
				appendicular skeleton, facial bones, vertebrae and medial clavicles
				are formed and relies on the tight control of chondrocyte
				maturation. Fibroblast growth factor receptor (FGFR)3 plays a role
				in bone development and maintenance and belongs to a family of
				proteins which differ in their ligand affinities and tissue
				distribution. Activating mutations of the FGFR3 gene lead to
				craniosynostosis and multiple types of skeletal dysplasia with
				varying degrees of severity: thanatophoric dysplasia (TD),
				achondroplasia and hypochondroplasia. Despite progress in the
				characterization of FGFR3-mediated regulation of cartilage
				development, many aspects remain unclear. The aim and the novelty of
				our study was to examine whole gene expression differences occurring
				in primary human chondrocytes isolated from normal cartilage or
				pathological cartilage from TD-affected fetuses, using Affymetrix
				technology. The phenotype of the primary cells was confirmed by the
				high expression of chondrocytic markers. Altered expression of genes
				associated with many cellular processes was observed, including cell
				growth and proliferation, cell cycle, cell adhesion, cell motility,
				metabolic pathways, signal transduction, cell cycle process and cell
				signaling. Most of the cell cycle process genes were down-regulated
				and consisted of genes involved in cell cycle progression, DNA
				biosynthesis, spindle dynamics and cytokinesis. About eight percent
				of all modulated genes were found to impact extracellular matrix
				(ECM) structure and turnover, especially glycosaminoglycan (GAG) and
				proteoglycan biosynthesis and sulfation. Altogether, the gene
				expression analyses provide new insight into the consequences of
				FGFR3 mutations in cell cycle regulation, onset of pre-hypertrophic
				differentiation and concomitant metabolism changes. Moreover,
				impaired motility and ECM properties may also provide clues about
				growth plate disorganization. These results also suggest that many
				signaling pathways may be directly or indirectly altered by FGFR3
				and confirm the crucial role of FGFR3 in the control of growth plate
				development.</text>
		</description>
		<protocol>
			<id>62</id>
			<accession>Affymetrix:Protocol:Hybridization-Unknown</accession>
		</protocol>
		<protocol>
			<id>77</id>
			<accession>P-AFFY-2</accession>
		</protocol>
		<protocol>
			<id>640003</id>
			<accession>P-MTAB-4886</accession>
		</protocol>
		<protocol>
			<id>640004</id>
			<accession>P-MTAB-4885</accession>
		</protocol>
		<protocol>
			<id>51</id>
			<accession>P-AFFY-6</accession>
		</protocol>
		<protocol>
			<id>640005</id>
			<accession>P-MTAB-4887</accession>
		</protocol>
		<organism>Homo sapiens</organism>
		<files><!--This section is deprecated and unsupported.Please use webservice 
				located at: http://www.ebi.ac.uk/arrayexpress/xml/filesto obtain detailed 
				information on files available for the experiment.For more information, please 
				go to: http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html -->
			<raw name="E-MEXP-2276.raw.1.zip" count="true" celcount="0" />
			<fgem name="E-MEXP-2276.processed.1.zip" available="true" />
			<idf name="E-MEXP-2276.idf.txt" />
			<sdrf name="E-MEXP-2276.sdrf.txt" />
		</files>
	</experiment>
</experiments>
